NCT03258294 Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease Status UNKNOWN Phase PHASE4
NCT03243214 Effect of Transcranial Magnetic Stimulation on Cognition and Neural Changes in Parkinson's Disease Status COMPLETED Phase NA
NCT03227783 The Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in PD Status UNKNOWN Phase NA
NCT03219892 rTMS for the Treatment of Freezing of Gait in Parkinson's Disease Status COMPLETED Phase NA
NCT03187301 A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes Status COMPLETED Phase PHASE2
NCT03173781 Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease Status COMPLETED Phase NA
NCT03131817 Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients Status COMPLETED Phase NA
NCT03119636 Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease Status UNKNOWN Phase PHASE1/PHASE2
NCT03111485 Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease Status COMPLETED Phase PHASE4
NCT03100474 Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders: Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03100149 A Study to Evaluate the Efficacy of Prasinezumab (RO7046015/PRX002) in Participants With Early Parkinson's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03065192 Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease Status COMPLETED Phase PHASE1
NCT03047629 Evaluation of Safety and Tolerability of ENT-01 for the Treatment of Parkinson's Disease Related Constipation Status COMPLETED Phase PHASE1/PHASE2
NCT03043768 Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease Status COMPLETED Phase N/A
NCT03026231 Characterization of Fecal Microbiome Changes After Administration of PRIM-DJ2727 in Parkinson's Disease Patients Status WITHDRAWN Phase PHASE1/PHASE2